glp 1 and cancer treatment Emerging Evidence Positions GLP-1 Receptor Agonists as a Novel Strategy to Reduce CRC Risk GLP-1 use linked to lower
Description
Bommer C, Heesemann E, Sagalova V, Manne-Goehler J, Atun R, Brnighausen T, Vollmer S
This dual mechanism is why tirzepatide outperforms single-agonist GLP-1 medications in head-to-head comparisons

The 35-54 cohort is spending more, dining out more, and actively trading up in quality, making it the single highest-opportunity segment for premium food brands and full-service restaurant concepts precisely as overall category volumes contract
A Mediterranean diet was found to result in higher GLP-1 release than a Western diet (Huber et al 2024)
